Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Polares
AddedFeb 17, 2024
UpdatedJun 18, 2026
Polares

Polares

Series B

Polares Medical: Innovating mitral valve regurgitation treatment with novel medical devices.

HQ
Palo Alto, CA, US
Founded
2017
Overview
Compare
Fundraising
Employees
Website

Polares Medical, founded with a mission to revolutionize the treatment of mitral valve regurgitation, is a pioneering medical device company. With operations based in Palo Alto, California, and Lausanne, Switzerland, Polares focuses on developing innovative solutions to address this critical heart condition. Their core product is a novel device designed to improve the outcomes for patients suffering from mitral valve regurgitation, aiming to provide a less invasive and more effective treatment option.

The company has garnered attention from notable figures in the medical and investment communities, contributing to its rapid growth and development. Polares Medical's advancements have positioned it as a significant player in the cardiovascular medical device market. Their novel approach has the potential to significantly impact patient care, offering new hope for those affected by mitral valve regurgitation.

Polares - Similar Companies

Half Moon Medical logo

Half Moon Medical

Polynova Cardiovascular logo

Polynova Cardiovascular

Cardiac Dimensions logo

Cardiac Dimensions

Nyra Medical logo

Nyra Medical

nyramed.com

PolyVascular logo

PolyVascular

polyvascular.com

Laplace Interventional logo

Laplace Interventional

laplaceint.com

Opus Medical Therapies logo

Opus Medical Therapies

opus-medical.com

MitraSpan logo

MitraSpan

4C Medical Technologies logo

4C Medical Technologies

4cmed.com

Capstan Medical logo

Capstan Medical

capstanmedical.com

Tau-Pnu Medical logo

Tau-Pnu Medical

Protaryx Medical logo

Protaryx Medical

protaryx.com

Palmera Medical logo

Palmera Medical

Renata Medical logo

Renata Medical

renatamedical.com

Zurich Medical logo

Zurich Medical

zurichmed.com

Polares - Quick Facts

Who are Polares' competitors?

Companies similar to Polares include Half Moon Medical, Polynova Cardiovascular, Cardiac Dimensions and Nyra Medical.

When was Polares founded?

Polares was founded in 2017.

Where is Polares' headquarters located?

Polares' headquarters is located in Palo Alto, CA, US.

When was Polares' last funding round?

Polares' most recent funding round was for $40M (USD) in June 2020.

How much has Polares raised to-date?

As of Jun 25, 2020, Polares has raised a total of $65M (USD).

How many employees does Polares have?

Polares has 30 employees as of Feb 4, 2024.

Polares - Classification

Industry
  • Hardware
Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified